The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Famotidine for Injection Market Research Report 2025
Synopsis
The global Famotidine for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Famotidine for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Famotidine for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Famotidine for Injection include Rakshit Drugs, Gauri Fine Chemicals, PAT IMPEX, Hainan Shuangcheng Pharmaceuticals, Hikma Pharmaceuticals, Baxter Healthcare, Athenex, Mylan Pharmaceuticals and Actiza Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Famotidine for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Famotidine for Injection.
Report Scope
The Famotidine for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Famotidine for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Famotidine for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Rakshit Drugs
Gauri Fine Chemicals
PAT IMPEX
Hainan Shuangcheng Pharmaceuticals
Hikma Pharmaceuticals
Baxter Healthcare
Athenex
Mylan Pharmaceuticals
Actiza Pharmaceutical
Omega Labs
Segment by Type
10mg/mL
20mg/mL
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Famotidine for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Famotidine for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Famotidine for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Famotidine for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Famotidine for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Famotidine for Injection include Rakshit Drugs, Gauri Fine Chemicals, PAT IMPEX, Hainan Shuangcheng Pharmaceuticals, Hikma Pharmaceuticals, Baxter Healthcare, Athenex, Mylan Pharmaceuticals and Actiza Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Famotidine for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Famotidine for Injection.
Report Scope
The Famotidine for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Famotidine for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Famotidine for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Rakshit Drugs
Gauri Fine Chemicals
PAT IMPEX
Hainan Shuangcheng Pharmaceuticals
Hikma Pharmaceuticals
Baxter Healthcare
Athenex
Mylan Pharmaceuticals
Actiza Pharmaceutical
Omega Labs
Segment by Type
10mg/mL
20mg/mL
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Famotidine for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Famotidine for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Famotidine for Injection Market Overview
1.1 Product Overview and Scope of Famotidine for Injection
1.2 Famotidine for Injection Segment by Type
1.2.1 Global Famotidine for Injection Market Value Comparison by Type (2024-2030)
1.2.2 10mg/mL
1.2.3 20mg/mL
1.3 Famotidine for Injection Segment by Application
1.3.1 Global Famotidine for Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Famotidine for Injection Market Size Estimates and Forecasts
1.4.1 Global Famotidine for Injection Revenue 2019-2030
1.4.2 Global Famotidine for Injection Sales 2019-2030
1.4.3 Global Famotidine for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Famotidine for Injection Market Competition by Manufacturers
2.1 Global Famotidine for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Famotidine for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Famotidine for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Famotidine for Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Famotidine for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Famotidine for Injection, Product Type & Application
2.7 Famotidine for Injection Market Competitive Situation and Trends
2.7.1 Famotidine for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Famotidine for Injection Players Market Share by Revenue
2.7.3 Global Famotidine for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Famotidine for Injection Retrospective Market Scenario by Region
3.1 Global Famotidine for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Famotidine for Injection Global Famotidine for Injection Sales by Region: 2019-2030
3.2.1 Global Famotidine for Injection Sales by Region: 2019-2024
3.2.2 Global Famotidine for Injection Sales by Region: 2025-2030
3.3 Global Famotidine for Injection Global Famotidine for Injection Revenue by Region: 2019-2030
3.3.1 Global Famotidine for Injection Revenue by Region: 2019-2024
3.3.2 Global Famotidine for Injection Revenue by Region: 2025-2030
3.4 North America Famotidine for Injection Market Facts & Figures by Country
3.4.1 North America Famotidine for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Famotidine for Injection Sales by Country (2019-2030)
3.4.3 North America Famotidine for Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Famotidine for Injection Market Facts & Figures by Country
3.5.1 Europe Famotidine for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Famotidine for Injection Sales by Country (2019-2030)
3.5.3 Europe Famotidine for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Famotidine for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Famotidine for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Famotidine for Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Famotidine for Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Famotidine for Injection Market Facts & Figures by Country
3.7.1 Latin America Famotidine for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Famotidine for Injection Sales by Country (2019-2030)
3.7.3 Latin America Famotidine for Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Famotidine for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Famotidine for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Famotidine for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Famotidine for Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Famotidine for Injection Sales by Type (2019-2030)
4.1.1 Global Famotidine for Injection Sales by Type (2019-2024)
4.1.2 Global Famotidine for Injection Sales by Type (2025-2030)
4.1.3 Global Famotidine for Injection Sales Market Share by Type (2019-2030)
4.2 Global Famotidine for Injection Revenue by Type (2019-2030)
4.2.1 Global Famotidine for Injection Revenue by Type (2019-2024)
4.2.2 Global Famotidine for Injection Revenue by Type (2025-2030)
4.2.3 Global Famotidine for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Famotidine for Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Famotidine for Injection Sales by Application (2019-2030)
5.1.1 Global Famotidine for Injection Sales by Application (2019-2024)
5.1.2 Global Famotidine for Injection Sales by Application (2025-2030)
5.1.3 Global Famotidine for Injection Sales Market Share by Application (2019-2030)
5.2 Global Famotidine for Injection Revenue by Application (2019-2030)
5.2.1 Global Famotidine for Injection Revenue by Application (2019-2024)
5.2.2 Global Famotidine for Injection Revenue by Application (2025-2030)
5.2.3 Global Famotidine for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Famotidine for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Rakshit Drugs
6.1.1 Rakshit Drugs Corporation Information
6.1.2 Rakshit Drugs Description and Business Overview
6.1.3 Rakshit Drugs Famotidine for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Rakshit Drugs Famotidine for Injection Product Portfolio
6.1.5 Rakshit Drugs Recent Developments/Updates
6.2 Gauri Fine Chemicals
6.2.1 Gauri Fine Chemicals Corporation Information
6.2.2 Gauri Fine Chemicals Description and Business Overview
6.2.3 Gauri Fine Chemicals Famotidine for Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Gauri Fine Chemicals Famotidine for Injection Product Portfolio
6.2.5 Gauri Fine Chemicals Recent Developments/Updates
6.3 PAT IMPEX
6.3.1 PAT IMPEX Corporation Information
6.3.2 PAT IMPEX Description and Business Overview
6.3.3 PAT IMPEX Famotidine for Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 PAT IMPEX Famotidine for Injection Product Portfolio
6.3.5 PAT IMPEX Recent Developments/Updates
6.4 Hainan Shuangcheng Pharmaceuticals
6.4.1 Hainan Shuangcheng Pharmaceuticals Corporation Information
6.4.2 Hainan Shuangcheng Pharmaceuticals Description and Business Overview
6.4.3 Hainan Shuangcheng Pharmaceuticals Famotidine for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hainan Shuangcheng Pharmaceuticals Famotidine for Injection Product Portfolio
6.4.5 Hainan Shuangcheng Pharmaceuticals Recent Developments/Updates
6.5 Hikma Pharmaceuticals
6.5.1 Hikma Pharmaceuticals Corporation Information
6.5.2 Hikma Pharmaceuticals Description and Business Overview
6.5.3 Hikma Pharmaceuticals Famotidine for Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hikma Pharmaceuticals Famotidine for Injection Product Portfolio
6.5.5 Hikma Pharmaceuticals Recent Developments/Updates
6.6 Baxter Healthcare
6.6.1 Baxter Healthcare Corporation Information
6.6.2 Baxter Healthcare Description and Business Overview
6.6.3 Baxter Healthcare Famotidine for Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Baxter Healthcare Famotidine for Injection Product Portfolio
6.6.5 Baxter Healthcare Recent Developments/Updates
6.7 Athenex
6.6.1 Athenex Corporation Information
6.6.2 Athenex Description and Business Overview
6.6.3 Athenex Famotidine for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Athenex Famotidine for Injection Product Portfolio
6.7.5 Athenex Recent Developments/Updates
6.8 Mylan Pharmaceuticals
6.8.1 Mylan Pharmaceuticals Corporation Information
6.8.2 Mylan Pharmaceuticals Description and Business Overview
6.8.3 Mylan Pharmaceuticals Famotidine for Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Pharmaceuticals Famotidine for Injection Product Portfolio
6.8.5 Mylan Pharmaceuticals Recent Developments/Updates
6.9 Actiza Pharmaceutical
6.9.1 Actiza Pharmaceutical Corporation Information
6.9.2 Actiza Pharmaceutical Description and Business Overview
6.9.3 Actiza Pharmaceutical Famotidine for Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Actiza Pharmaceutical Famotidine for Injection Product Portfolio
6.9.5 Actiza Pharmaceutical Recent Developments/Updates
6.10 Omega Labs
6.10.1 Omega Labs Corporation Information
6.10.2 Omega Labs Description and Business Overview
6.10.3 Omega Labs Famotidine for Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Omega Labs Famotidine for Injection Product Portfolio
6.10.5 Omega Labs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Famotidine for Injection Industry Chain Analysis
7.2 Famotidine for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Famotidine for Injection Production Mode & Process
7.4 Famotidine for Injection Sales and Marketing
7.4.1 Famotidine for Injection Sales Channels
7.4.2 Famotidine for Injection Distributors
7.5 Famotidine for Injection Customers
8 Famotidine for Injection Market Dynamics
8.1 Famotidine for Injection Industry Trends
8.2 Famotidine for Injection Market Drivers
8.3 Famotidine for Injection Market Challenges
8.4 Famotidine for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
